Macdonald Guy 4
4 · TETRAPHASE PHARMACEUTICALS INC · Filed Dec 9, 2019
Insider Transaction Report
Form 4
Macdonald Guy
DirectorPresident and Chief Executive
Transactions
- Sale
Common Stock
2019-12-05$2.34/sh−1,870.35$4,377→ 5,985.05 total - Sale
Common Stock
2019-12-06$2.25/sh−5,734.65$12,903→ 250.4 total
Footnotes (3)
- [F1]The number of shares of common stock reported on this Form 4 reflects a 1-for -20 reverse stock split effected on September 26, 2019.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $2.34 to $2.35 per share. The reporting person herby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission,the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $2.25 to $2.29 per share. The reporting person herby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission,the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.